ANAVEX LIFE SCIENCES CORP. (AVXL)
$2.99-$0.14 (-4.50%) Today
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.
No Form 4 activity for AVXL in the last 90 days.
12 Form 4 filings on record, the earliest from Dec 6, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Christopher U. Missling - Officer | Grant or award | Stock Option (Right to Buy) | 125,000 | $0.00 | - | |
| Sandra Boenisch - Officer | Grant or award | Stock Option (Right to Buy) | 12,500 | $0.00 | - | |
| Christopher U. Missling - Officer | Grant or award | Stock Option (Right to Buy) | 125,000 | $0.00 | - | |
| Sandra Boenisch - Officer | Grant or award | Stock Option (Right to Buy) | 12,500 | $0.00 | - | |
| Christopher U. Missling - Officer | Option exercise | Common Stock | 187,500 | $5.04 | $945K | |
| Christopher U. Missling - Officer | Tax withholding / forfeiture | Common Stock | 145,048 | $9.58 | $1.39M | |
| Christopher U. Missling - Officer | Option exercise | Stock Option (Right to Buy) | 187,500 | $0.00 | - | |
| Sandra Boenisch - Officer | Grant or award | Stock Option (Right to Buy) | 12,500 | $0.00 | - | |
| Christopher U. Missling - Officer | Grant or award | Stock Option (Right to Buy) | 125,000 | $0.00 | - | |
| Christopher U. Missling - Officer | Grant or award | Stock Option (Right to Buy) | 125,000 | $0.00 | - | |
| Sandra Boenisch - Officer | Grant or award | Stock Option (Right to Buy) | 12,500 | $0.00 | - | |
| Christopher U. Missling - Officer | Grant or award | Stock Option (Right to Buy) | 125,000 | $0.00 | - | |
| Christopher U. Missling - Officer | Grant or award | Stock Option (Right to Buy) | 125,000 | $0.00 | - | |
| Sandra Boenisch - Officer | Grant or award | Stock Option (Right to Buy) | 10,000 | $0.00 | - |
ANAVEX LIFE SCIENCES CORP. (AVXL) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-01-09. The full record for AVXL runs to 12 Form 4 filings, the earliest from 2024-12-06. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of AVXL were filed in the last 90 days.
No insider sales of AVXL were filed in the last 90 days.
This page tracks AVXL Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add AVXL to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
